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Pharmaceuticals have been detected in wastewater treatment plants, rivers, and groundwater 
and even in drinking water. This poses potential risks for aquatic organisms and ecosystems in 
particular, although possible future effects on human health cannot be ruled out. Therefore, 
developing sensitive and selective analytical methods for monitoring of metabolites and active 
drugs in aqueous environments is an important task in exposure analysis.  
The analytical techniques usually used e.g. HPLC-UV-MS or GC-MS, still afford an efficient 
sample pretreatment to enrich and separate the analytes from complex matrix. The aim of this 
study was to investigate the applicability of bulk liquid membranes and supported liquid 
membranes (SLM) to extract efficiently selected drugs of environmental concern and some of 
their metabolites from water samples. 
The active drugs carbamazepine, diclofenac, ibuprofen and sulfamethoxazole were selected 
due to their high quantity applied for medical purposes and their relative high concentrations 
found in the aquatic environment in previous studies. The metabolites 10,11-dihydroxy-
carbamazepine, 4-hydroxy-ibuprofen, N-4-acetyl-sulfamethoxazole, sulfamethoxazol-N1-
glucuronide are not commercially available, they were synthesized and also used in 
membrane systems. Several factors affecting the transport in the membrane chambers such as 
the membrane composition, pH of feed and strip phase, and enrichment time were studied. 
By means of the supported liquid flat-membrane chamber (SL-FM), 4-hydroxy-ibuprofen and 
N-4-acetyl-sulfamethoxazole were efficiently extracted by combining an organic solvent 
dihexyl ether (DHE), decane or undecane with tri-n-octylphosphine oxide (TOPO) as a carrier 
and a pH-gradient between feed and strip phases. Maximum extraction yields ~ 90% of 4-
hydroxy-ibuprofen and ~ 85% of N-4-acetyl-sulfamethoxazole were obtained by using DHE 
with 10% (w/w) of TOPO, at an analyte concentration of 1 mg/L after 8-hours of extraction.  
Enrichment devices were constructed based on supported liquid bag membrane systems, to 
enrich trace target analytes from water samples and determine them by means of HPLC-UV. 
These systems contained one bag (SL-BM) or four bags (SL-4-BM).  
Using the SL-4-BM equipment 45% of 4-hydroxy-ibuprofen, 55% of N-4-acetyl-
sulfamethoxazole, 30% of diclofenac, and 50% of ibuprofen, were extracted from 500 mL of 
sample volume and enriched into 0.4 µL of strip solution (0.1 mol/L NaOH). Enrichment 
factors in the range of 383- 727 were obtained in a concentration range from 1-100 µg/L after 
4-hours of extraction.  
The results of an investigation show that in comparison to solid phase extraction (SPE), the 
novel SL-4-BM system offers advantages due to higher enrichment factors, more efficient 
clean-up-effects, low consume of organic solvents and time.  
To prove if the SL-4-BM is robust against interferences, the sample matrix was varied. It can 
be recognized that in the range of 0.3- 1.5 µg/L the type of spiked water sample (distilled, tap 
and surface water) had no noticeable influence in the extraction recoveries.  
The SL-4-BM method was applied to real samples from the river Ruhr. The surface water 
sample was evidently not polluted by the target analytes as they were not detectable by means 
of the membrane method and HPLC (method detection limits ~ 0.07- 0.2 µg/L).  
